The board of MEI Pharma (US:MEIP), a San Diego-based oncology company, is under fire from prominent shareholders who argue that a proposed merger with Infinity Pharmaceuticals (US:INFI) undervalues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results